INTERNATIONAL JOURNAL FOR INNOVATIVE RESEARCH IN MULTIDISCIPLINARY FIELD

Abstract: Fungi belonging to the order Mucorales can cause mucormycosis, an uncommon but aggressive opportunistic fungal infection. An unexpected increase in COVID-19-associated mucormycosis (CAM) was documented during the second wave of the COVID-19 pandemic in India (2021), especially in patients with diabetes mellitus and those on systemic corticosteroids. With a focus on the Indian situation during the COVID-19 pandemic, this paper highlights the epidemiology, risk factors, clinical symptoms, diagnostic techniques, therapeutic options, outcomes, and preventative measures associated with mucormycosis. To lower morbidity and mortality related to this potentially fatal illness, early identification, timely antifungal medication, surgical intervention, and management of underlying risk factors are essential.